AstraZeneca
AZN
#70
Rank
C$351.91 B
Marketcap
C$226.91
Share price
0.06%
Change (1 day)
-5.95%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): C$9.26

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$9.54. In 2024 the company made an earnings per share (EPS) of C$6.48 an increase over its 2023 EPS that were of C$5.48.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$9.26
2024C$6.4818.23%
2023C$5.4881.13%
2022C$3.03631.03%
2021C$0.41-88.11%
2020C$3.48136.89%
2019C$1.47-39.41%
2018C$2.43-28.27%
2017C$3.38-14.37%
2016C$3.9524.11%
2015C$3.18127.55%
2014C$1.40-51.96%
2013C$2.91-58.95%
2012C$7.10-32.2%
2011C$10.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.47 30.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.51-0.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.09-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$4.45-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.68 347.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.72-71.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$8.11-14.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.81-81.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48-32.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.57-52.13%๐Ÿ‡ฌ๐Ÿ‡ง UK